Subtopic Deep Dive

← Glutathione Transferases and Polymorphisms

GST Role in Anticancer Drug Metabolism
Research Guide

What is GST Role in Anticancer Drug Metabolism?

GST enzymes conjugate glutathione to electrophilic anticancer drugs, detoxifying them and contributing to multidrug resistance in tumors.

Glutathione S-transferases (GSTs) catalyze phase II detoxification by conjugating glutathione (GSH) to chemotherapeutic agents (Sheehan et al., 2001, 1522 citations). Elevated GST expression in cancer cells inactivates drugs like alkylating agents and platinum compounds, promoting chemoresistance (Traverso et al., 2013, 1156 citations). Research spans kinetic assays, tumor expression profiling, and GST polymorphisms affecting drug metabolism.

Curated Papers

Key Challenges

Why It Matters

GST-mediated detoxification reduces intracellular drug concentrations, enabling tumor survival during chemotherapy (Traverso et al., 2013). Nrf2-Keap1 pathway activation upregulates GSTs, exacerbating resistance in lung cancer (Jaramillo and Zhang, 2013; Singh et al., 2006). Curcumin induces GSTs, modulating drug efficacy in clinical trials (Sharma et al., 2004). Pharmacogenomic profiling of GST polymorphisms guides personalized dosing to overcome resistance (Lushchak, 2012). GSH homeostasis targeting enhances therapy outcomes (Kennedy et al., 2020).

Key Research Challenges

Quantifying GST-drug kinetics

Measuring conjugation rates of specific chemotherapeutics by tumor GST isoforms remains inconsistent across cell lines. Variability arises from substrate specificity and GSH levels (Sheehan et al., 2001). Kinetic modeling requires standardized assays for clinical translation (Lushchak, 2012).

Linking polymorphisms to resistance

GST polymorphisms like GSTM1-null alter drug metabolism, but population-specific effects complicate predictions. Functional validation in patient cohorts is limited (Traverso et al., 2013). Haplotype analysis integrating Nrf2 regulation is needed (Jaramillo and Zhang, 2013).

Overcoming Nrf2-mediated GST upregulation

Constitutive Nrf2 activation in NSCLC drives GST overexpression, sustaining resistance despite inhibitors. Keap1 mutations hinder pathway blockade (Singh et al., 2006). Combinatorial therapies targeting both axes show promise but lack validation (Jaramillo and Zhang, 2013).

Essential Papers

Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily

David Sheehan, Gerardene MEADE, Vivienne Foley et al. · 2001 · Biochemical Journal · 1.5K citations

The glutathione transferases (GSTs; also known as glutathione S-transferases) are major phase II detoxification enzymes found mainly in the cytosol. In addition to their role in catalysing the conj...

The emerging role of the Nrf2–Keap1 signaling pathway in cancer

Melba C. Jaramillo, Donna D. Zhang · 2013 · Genes & Development · 1.3K citations

The Nrf2 (nuclear factor erythroid 2 [NF-E2]-related factor 2 [Nrf2])–Keap1 (Kelch-like erythroid cell-derived protein with CNC homology [ECH]-associated protein 1) signaling pathway is one of the ...

Phase I Clinical Trial of Oral Curcumin

Ricky A. Sharma, Stephanie A. Euden, Sharon L. Platton et al. · 2004 · Clinical Cancer Research · 1.2K citations

Abstract Curcumin, a polyphenolic antioxidant derived from a dietary spice, exhibits anticancer activity in rodents and in humans. Its efficacy appears to be related to induction of glutathione S-t...

Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions

Volodymyr I. Lushchak · 2012 · Journal of Amino Acids · 1.2K citations

Glutathione (GSH) is a tripeptide, which has many biological roles including protection against reactive oxygen and nitrogen species. The primary goal of this paper is to characterize the principal...

Role of Glutathione in Cancer Progression and Chemoresistance

Nicola Traverso, Roberta Ricciarelli, Mariapaola Nitti et al. · 2013 · Oxidative Medicine and Cellular Longevity · 1.2K citations

Glutathione (GSH) plays an important role in a multitude of cellular processes, including cell differentiation, proliferation, and apoptosis, and disturbances in GSH homeostasis are involved in the...

Glutathione dysregulation and the etiology and progression of human diseases

Nazzareno Ballatori, Suzanne M. Krance, Sylvia Notenboom et al. · 2009 · Biological Chemistry · 1.1K citations

Abstract Glutathione (GSH) plays an important role in a multitude of cellular processes, including cell differentiation, proliferation, and apoptosis, and as a result, disturbances in GSH homeostas...

Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer

Anju Singh, Vikas Misra, Rajesh K. Thimmulappa et al. · 2006 · PLoS Medicine · 1.0K citations

This is the first study to our knowledge to demonstrate that biallelic inactivation of KEAP1 is a frequent genetic alteration in NSCLC. Loss of KEAP1 function leading to constitutive activation of ...

Reading Guide

Foundational Papers

Start with Sheehan et al. (2001, 1522 citations) for GST structure-function; Traverso et al. (2013, 1156 citations) for cancer chemoresistance role; Jaramillo and Zhang (2013, 1282 citations) for Nrf2 pathway integration.

Recent Advances

Kennedy et al. (2020, 777 citations) reviews GSH therapies; Snezhkina et al. (2019, 860 citations) covers ROS-GST in malignancy.

Core Methods

GST activity via CDNB conjugation assays; polymorphism genotyping by PCR-RFLP; Nrf2 activity by ARE-luciferase reporters; GSH levels by HPLC; kinetic modeling with Lineweaver-Burk plots.

How PapersFlow Helps You Research GST Role in Anticancer Drug Metabolism

Discover & Search

Research Agent uses searchPapers('GST anticancer drug metabolism polymorphisms') to retrieve 50+ papers including Sheehan et al. (2001), then citationGraph reveals Nrf2-GST clusters from Jaramillo and Zhang (2013). findSimilarPapers on Traverso et al. (2013) uncovers polymorphism studies; exaSearch drills into kinetic data across 250M+ OpenAlex papers.

Analyze & Verify

Analysis Agent applies readPaperContent to extract GST kinetic parameters from Sheehan et al. (2001), then runPythonAnalysis with pandas fits Michaelis-Menten curves to raw data. verifyResponse (CoVe) cross-checks claims against 10 similar papers; GRADE grading scores evidence strength for Traverso et al. (2013) chemoresistance mechanisms.

Synthesize & Write

Synthesis Agent detects gaps in polymorphism-clinical outcome links via contradiction flagging across Traverso (2013) and Kennedy (2020). Writing Agent uses latexEditText for methods sections, latexSyncCitations imports BibTeX from 20 GST papers, and latexCompile generates review manuscripts. exportMermaid visualizes Nrf2-GST-drug conjugation pathways.

Use Cases

"Analyze GST enzyme kinetics for cisplatin detoxification from tumor cell data"

Research Agent → searchPapers → Analysis Agent → readPaperContent(Sheehan 2001) → runPythonAnalysis(pandas curve fitting, matplotlib Km/Vmax plots) → researcher gets quantified kinetic parameters and resistance predictions.

"Write LaTeX review on Nrf2-GST axis in lung cancer chemoresistance"

Synthesis Agent → gap detection → Writing Agent → latexEditText(draft) → latexSyncCitations(Jaramillo 2013, Singh 2006) → latexCompile → researcher gets compiled PDF with figures and synced references.

"Find open-source code for GST polymorphism simulation models"

Research Agent → paperExtractUrls(Traverso 2013) → paperFindGithubRepo → githubRepoInspect → researcher gets runnable Python scripts for haplotype-drug response modeling.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers(50 GST-drug papers) → citationGraph → DeepScan(7-step verification with CoVe checkpoints) → structured report on polymorphism impacts. Theorizer generates hypotheses linking GST induction by curcumin (Sharma 2004) to Nrf2 polymorphisms. DeepScan analyzes Traverso (2013) for chemoresistance mechanisms with GRADE scoring.

Try Doxa for GST Role in Anticancer Drug Metabolism Research

Frequently Asked Questions

What defines GST role in anticancer drug metabolism?

GSTs conjugate GSH to electrophilic drugs like cisplatin, neutralizing them and causing resistance (Sheehan et al., 2001).

What methods study GST-drug interactions?

Kinetic assays measure conjugation rates; qPCR profiles tumor GST expression; Nrf2 inhibitors test pathway dependence (Jaramillo and Zhang, 2013; Traverso et al., 2013).

What are key papers on this topic?

Sheehan et al. (2001, 1522 citations) details GST catalysis; Traverso et al. (2013, 1156 citations) covers chemoresistance; Jaramillo and Zhang (2013, 1282 citations) explains Nrf2 regulation.

What open problems exist?

Validating GST polymorphisms for personalized dosing; developing isoform-specific inhibitors; integrating GSH homeostasis with Nrf2-targeted therapies (Kennedy et al., 2020; Singh et al., 2006).